Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.9M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+362K
-
Total reported value, excl. options
-
$296M
-
Value change
-
-$1.42M
-
Put/Call ratio
-
0.85
-
Number of buys
-
57
-
Number of sells
-
-82
-
Price
-
$22.05
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2016
163 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q2 2016.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 27.9M outstanding shares and own 48.13% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (1.2M shares), EAGLE ASSET MANAGEMENT INC (1M shares), Krensavage Asset Management, LLC (907K shares), FMR LLC (701K shares), ACADIAN ASSET MANAGEMENT LLC (690K shares), STATE STREET CORP (652K shares), VANGUARD GROUP INC (651K shares), Fiera Capital Corp (566K shares), GREAT POINT PARTNERS LLC (538K shares), and SENZAR ASSET MANAGEMENT, LLC (482K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.